One Health: Human, Animal, and Environment Triad

دانلود کتاب One Health: Human, Animal, and Environment Triad

33000 تومان موجود

کتاب یک سلامت: سه گانه انسان، حیوان و محیط زیست نسخه زبان اصلی

دانلود کتاب یک سلامت: سه گانه انسان، حیوان و محیط زیست بعد از پرداخت مقدور خواهد بود
توضیحات کتاب در بخش جزئیات آمده است و می توانید موارد را مشاهده فرمایید


در صورت ایرانی بودن نویسنده امکان دانلود وجود ندارد و مبلغ عودت داده خواهد شد

این کتاب نسخه اصلی می باشد و به زبان فارسی نیست.


امتیاز شما به این کتاب (حداقل 1 و حداکثر 5):

امتیاز کاربران به این کتاب:        تعداد رای دهنده ها: 2


توضیحاتی در مورد کتاب One Health: Human, Animal, and Environment Triad

نام کتاب : One Health: Human, Animal, and Environment Triad
عنوان ترجمه شده به فارسی : یک سلامت: سه گانه انسان، حیوان و محیط زیست
سری :
نویسندگان : ,
ناشر : Wiley
سال نشر :
تعداد صفحات : 492
ISBN (شابک) : 9781119867302 , 1119867304
زبان کتاب : English
فرمت کتاب : pdf
حجم کتاب : 192 مگابایت



بعد از تکمیل فرایند پرداخت لینک دانلود کتاب ارائه خواهد شد. درصورت ثبت نام و ورود به حساب کاربری خود قادر خواهید بود لیست کتاب های خریداری شده را مشاهده فرمایید.


فهرست مطالب :


Cover\nTitle Page\nCopyright Page\nContents\nList of Contributors\nPreface\nSection I One Health Approach\n Chapter 1 The Need for One Health Approach at the Recent Anthropocene\n 1.1 Anthropocene\n 1.2 Infectious Diseases: Animals to Humans\n 1.3 Emerging and Reemerging Infectious Diseases\n 1.4 Definition of One Health\n 1.5 Other Paradigms to One Health\n 1.6 One Health Fundamentals\n 1.7 International Health Regulations and Its Evaluation Mechanisms\n 1.8 Global Health Security Agenda\n 1.8.1 Zoonotic Diseases\n 1.8.2 Antimicrobial Resistance\n 1.8.3 Food Safety and Food Security\n 1.8.4 Vector-Borne Disease\n 1.8.5 Environmental Contamination\n 1.9 COVID-19 and One Health\n 1.10 Road Map for One Health\n 1.11 Challenges of One Health Approach\n Acknowledgment\n References\n Chapter 2 Emergence and Re-emergence of Emerging Infectious Diseases (EIDs): Looking at “One Health” Through the Lens of Ecology\n 2.1 Introduction\n 2.2 Emerging Infectious Diseases\n 2.3 Genesis of EIDs: Tracing from Natural History\n 2.4 Global Trends of EIDs\n 2.5 Changes in Pathogen, Vector, and Human Ecology: A Faustian Bargain for EIDs\n 2.6 Forests and Emerging Infectious Diseases: Unleashing the Beast Within\n 2.6.1 Forest-Derived Human Infections\n 2.6.1.1 Kyasanur Forest Disease\n 2.6.1.2 Nipah Virus\n 2.6.1.3 Hantavirus\n 2.6.1.4 Mycobacterium ulcerans/Buruli Ulcer\n 2.6.1.5 HIV/AIDS\n 2.6.1.6 Malaria\n 2.6.1.7 Lyme Disease\n 2.7 Humans as the Dominant Driver of Emergence and Resurgence of EIDs\n 2.8 Global Warming and EIDs\n 2.8.1 Interactions Between Climate Change and Pathogens\n 2.9 COVID-19: The Latest Avatar of the EID\n 2.10 Mitigation\n 2.11 Conclusion\n References\n Chapter 3 Environmental Interfaces for One Health\n 3.1 Environment is the Most Dynamic Component of the One Health Triad\n 3.2 Anthropogenic Alteration of Natural Landscapes Reduces Biodiversity and Promotes Emergence and Spread of Infectious Diseases\n 3.3 Climate Change Modify the Behavior of Reservoir Species of Zoonotic Pathogens and the Viability of the Pathogens in the Environment\n 3.4 Urbanization Creates Novel Habitats for Adaptable Species and New Niches for Diseases\n 3.5 Antimicrobial Resistance (AMR) Is One of the Largest Threats to Global Public Health\n 3.6 Transmission Dynamics of AMR in the Environmental and Wildlife Are Less Understood, or Neglected\n 3.7 Major Anthropogenic Drivers of Zoonotic Disease Emergence Also Drives the Emergence and Spread of AMR in Environment\n 3.8 Food-Producing Environments Play a Critical Role in the Emergence and Spread of AMR\n 3.9 Wildlife Also Plays a Very Significant Role in the Ecology and Dissemination of AMR\n 3.10 AMR is Not Monitored Regularly Using Standard Methods\n 3.11 Global and National Action Plans on AMR\n References\n Chapter 4 Zoonoses: The Rising Threat to Human Health\n 4.1 What is a Zoonotic Disease?\n 4.2 Classification of Zoonotic Diseases\n 4.3 Direct Contact\n 4.4 Indirect Contact\n 4.4.1 Vector-Borne Zoonotic Diseases\n 4.4.1.1 Definition and Transmission\n 4.4.1.2 Common Examples\n 4.4.1.3 Prevention and Control\n 4.4.2 Foodborne Zoonoses\n 4.4.2.1 Definition and Transmission\n 4.4.2.2 Common Examples\n 4.4.2.3 Prevention and Control\n 4.4.3 Waterborne Zoonoses\n 4.4.3.1 Definition and Transmission\n 4.4.3.2 Common Examples\n 4.4.3.3 Control and Prevention\n 4.4.4 Airborne Zoonoses\n 4.4.4.1 Definition and Transmission\n 4.4.4.2 Common Examples\n 4.4.4.3 Control and Prevention\n 4.4.5 Zoonoses Contracted via Contaminated Soil and Surfaces\n 4.5 Who Is at Risk of Zoonoses?\n 4.6 Factors Contributing to the Emergence and Reemergence of Zoonotic Diseases\n 4.7 Prevention of Zoonotic Diseases\n 4.8 One Health Initiative\n References\n Chapter 5 Microplastics in Soil and Water: Vector Behavior\n 5.1 Introduction\n 5.2 Concentrations of Inorganic Pollutants Adsorbed on Microplastics\n 5.3 Concentrations of Organic Micropollutants Adsorbed on Microplastics\n 5.4 Microplastics as Source of Plastic Additives and Decomposition Products\n 5.5 Microplastics as a Base for Microorganisms Growth\n 5.6 Conclusions\n References\nSection II Environmental Domains for One Health\n Chapter 6 Cyanotoxin in Hydrosphere and Human Interface\n 6.1 Introduction\n 6.2 Cyanobacteria and Cyanotoxins\n 6.2.1 Cyanobacteria and Cyanotoxins\n 6.2.2 Occurrence of Cyanobacteria in the Hydrosphere\n 6.2.3 Impacts of Climate Changes on Cyanobacterial Occurrence in the Hydrosphere\n 6.2.4 Impacts of Anthropogenic Activities on Cyanobacterial Occurrence in the Hydrosphere\n 6.3 Modes of Human Exposure to Cyanotoxins and Illnesses Associated with Cyanotoxins\n 6.3.1 Modes of Human Exposure to Cyanotoxins\n 6.3.2 Illnesses Associated with Cyanotoxins\n 6.3.2.1 Human Illnesses\n 6.3.2.2 Animal Intoxications\n 6.4 The Future Directions for Effective Risk Management of Toxic Cyanobacteria\n 6.5 Conclusion\n Acknowledgment\n References\n Chapter 7 Contributions to One Health Approach to Solve Geogenic Health Issues\n 7.1 Introduction\n 7.2 Medical Geology – Historical Perspective\n 7.3 Pathways of Elements in the Geoenvironment\n 7.4 The Hydrologic Cycle and One Health\n 7.5 Geology and Health – Some Examples\n 7.5.1 Fluoride\n 7.5.2 Arsenic\n 7.5.3 Uranium and Radon\n 7.6 Conclusions\n References\n Chapter 8 Disasters: Health and Environment Interphase\n 8.1 Key Terminology on Disasters\n 8.1.1 Vulnerability\n 8.1.2 Exposure\n 8.1.3 Capacity\n 8.1.4 Disaster Risk\n 8.2 Effects of Disasters on Environment and Health\n 8.3 Managing Natural Disasters to Minimize Effects on Human Health\n 8.4 Shifting the Focus: Response to Disaster Risk Management\n 8.5 Resilience: A New Paradigm\n 8.5.1 Health Systems Resilience\n 8.5.2 Community Resilience\n 8.6 Areas for Future Research and Practice\n Acknowledgment\n References\n Chapter 9 Role of Microorganisms in Bioavailability of Soil Pollutants\n 9.1 Introduction\n 9.2 Soil Pollution: The Global Scenario\n 9.3 Types of Soil Pollutants\n 9.4 Emerging Pollutants\n 9.5 Fates of Soil Pollutants\n 9.6 Why Microbes?\n 9.7 Organic Soil Pollutants\n 9.7.1 Chemotaxis\n 9.7.2 Cell Surface Properties\n 9.7.3 Biosurfactants\n 9.7.4 Pesticides\n 9.7.5 Petroleum Hydrocarbons\n 9.8 Potentially Toxic Elements (Heavy Metals)\n 9.8.1 Rhizosphere Microorganisms\n 9.9 Microplastics\n 9.9.1 Nanomaterials\n 9.10 A Final Inference\n References\n Chapter 10 Per-and Polyfluoroalkyl Substances (PFAS) Migration from Water to Soil–Plant Systems, Health Risks, and Implications for Remediation\n 10.1 Introduction\n 10.2 Sources of PFAS Contamination\n 10.2.1 Aqueous Film-Forming Foams (AFFFs)\n 10.2.2 Landfill Effluents\n 10.2.3 Wastewater Effluents and Biosolids\n 10.3 Biotransformation of PFAS\n 10.4 Transportation and Occurrence of PFAS in Water Resources\n 10.4.1 PFAS in Surface Water Resources\n 10.4.2 PFAS in Groundwater\n 10.5 PFAS in Soil and Interactions\n 10.5.1 PFAS and Soil Microbiome\n 10.6 Plant Interactions and Uptake of PFAS\n 10.7 Health Risks of PFAS\n 10.8 Implications for Remediation\n 10.9 Recommendations and Future Research Directions\n References\n Chapter 11 One Health Relationships in Microbe–Human Domain\n 11.1 Microbial Domain in Human\n 11.2 Normal Bacterial Makeup of the Body\n 11.2.1 Skin Microbiota\n 11.2.2 Oral Microbiota\n 11.2.3 Respiratory System Microbiota\n 11.2.4 Gut Microbiota\n 11.2.5 Urogenital Microbiota\n 11.3 How Microbiome Impact on Human Health and Homeostasis\n 11.3.1 Metabolism of Nutrients and Other Food Components\n 11.3.2 Synthesis of Essential Vitamins\n 11.3.3 Host Bile Acids and Cholesterol Metabolism\n 11.3.4 Drug Metabolism\n 11.3.5 Defense Against Pathogens\n 11.3.6 Immune Modulation\n 11.4 Factors That Influence the Microbial Domain Due to Interactions Between Humans, Animals, Plants, and Our Environment\n 11.4.1 Human Population Expansion into New Geographic Areas\n 11.4.2 Climate Changes and Anthropogenic Activities\n 11.4.3 Development of International Travel and Trade Movements\n 11.4.4 Urbanization\n 11.4.5 Chemical Pollution\n 11.5 One Health Threats\n 11.5.1 Zoonotic Diseases\n 11.5.2 Antimicrobial Resistance\n 11.5.3 Vector-Borne Diseases\n 11.6 Animals as Early Warning Signs of Potential Human Illness\n 11.7 Tools for Studying the Shared Microbiome\n 11.7.1 Sequencing Methods, Technological Advances for Studying the Microbiome\n 11.7.1.1 Marker-Based Microbiome Profiling\n 11.7.1.2 Shotgun Metagenomics\n 11.7.1.3 Metatranscriptomics, Metabolomics, and Metaproteomics\n 11.7.2 Bioinformatic Tools for Studying the Microbiome\n 11.7.2.1 Microbial Diversity Measurements\n 11.7.2.2 Functional Analysis of Microbiome\n 11.7.2.3 Statistical Analysis and Data Visualization\n 11.7.3 Systems for Studying the Microbiome\n 11.7.3.1 Considerations in Sampling the Human Microbiome\n 11.7.3.2 Culture Systems for Characterizing the Human Microbiome\n 11.7.3.3 Understanding the Human Microbiome by Using Model Organisms\n 11.7.3.4 Engineered Systems for Studying Human–Microbiome Interactions (in vitro and ex vivo Models)\n 11.8 Concluding Remarks\n References\n Chapter 12 Biomedical Waste During COVID-19: Status, Management, and Treatment\n 12.1 Introduction\n 12.2 Composition of Healthcare Waste\n 12.3 Waste Management Strategies During COVID-19 Pandemic\n 12.4 Treatment of BMW During COVID-19\n 12.5 Healthcare Solid Waste Treatment Techniques\n 12.5.1 On-Site Medical Waste Treatment\n 12.5.1.1 Autoclaving\n 12.5.1.2 Chemical Treatment\n 12.5.1.3 Microwave Treatment\n 12.5.2 Off-Site Medical Waste Disposal\n 12.5.2.1 Incineration\n 12.5.2.2 Land Disposal\n 12.5.2.3 Plasma Pyrolysis\n 12.5.2.4 Encapsulation and Inertization\n 12.5.3 Other Emerging Technologies\n 12.6 Future Aspects and Conclusion\n References\n Chapter 13 Spatiotemporal Dynamics of Disease Transmission: Learning from COVID-19 Data\n 13.1 Introduction\n 13.2 Data Processing\n 13.2.1 Study Area and Study Period\n 13.2.2 Data Visualization\n 13.3 Spatial Autocorrelation\n 13.3.1 Moran’s I\n 13.3.2 Moran Scatter Plot\n 13.3.3 Optimal Weight Function\n 13.4 Spatiotemporal Analysis\n 13.4.1 Dynamics of Moran’s I\n 13.4.2 Illustrations of Moran Scatters\n 13.4.3 Risk Mapping\n 13.5 Discussion\n Acknowledgments\n References\n Chapter 14 Organic Farming: The Influence on Soil Health\n 14.1 Introduction\n 14.1.1 Concept of Organic Farming\n 14.1.1.1 Principles of Health\n 14.1.1.2 Principles of Ecology\n 14.1.1.3 Principles of Fairness\n 14.1.1.4 Principles of Care\n 14.1.2 Global Scenario of Organic Farming\n 14.1.3 Organic Farming vs. Conventional Farming\n 14.1.3.1 Biodynamic Agriculture\n 14.2 Soil Health\n 14.2.1 Soil Health vs. Soil Quality\n 14.2.1.1 Soil Health Indicators\n 14.2.1.2 Soil Health Management and Soil Health Principles\n 14.3 Organic Farming Affecting Soil Health: Soil Physical, Chemical, and Biological Properties\n 14.3.1 Effect of Organic Farming on Soil Physical Properties\n 14.3.2 Effect of Organic Farming on Soil Chemical Properties\n 14.3.3 Effect of Organic Farming on Soil Biological Properties\n 14.4 Organic Farming Toward One Health\n 14.5 Challenges, Trends, and Prospects\n References\n Chapter 15 Chronic Kidney Disease with Uncertain Etiology in Sri Lanka: Selected Case Studies\n 15.1 Introduction\n 15.2 Prevalence of CKDu in Sri Lanka\n 15.3 Etiology of CKDu\n 15.4 Influence of Hydro-geochemical Quality of Drinking Water\n 15.4.1 Fluoride and Hardness\n 15.4.2 Toxic Trace Metals\n 15.4.3 Agrochemical Usage and Food Contamination\n 15.5 Influence of Biochemical Factors on CKDu\n 15.5.1 Dissolved Organic Carbon (DOC) in groundwater\n 15.5.2 Cyanotoxins\n 15.5.3 Heat Stress\n 15.6 Future Directions\n References\n Chapter 16 Waste in One Health: Building Resilient Communities Through Sustainable Waste Management\n 16.1 Introduction\n 16.2 Waste and Environmental Health\n 16.3 Waste and Human Health\n 16.4 Waste and Animal Health\n 16.5 Waste Management During and Post-COVID-19 Pandemic\n 16.6 Futuristic Approaches in Waste Management\n 16.6.1 Waste Management in a Circular Economy\n 16.6.2 Waste Management in Smart Cities\n 16.6.3 New and Emerging Technologies in Waste Management\n 16.7 Final Remarks\n References\n Chapter 17 One Health Approach for Eye Care: Is It a Boon or Hype\n Abbreviations\n 17.1 Introduction\n 17.2 Eye – The Visual Organ\n 17.3 Eye Diseases\n 17.4 Cornea and Its Diseases\n 17.4.1 Corneal Injury\n 17.4.2 Epithelial Injury\n 17.4.3 Microbial Infection\n 17.4.4 Gradation of the Damage\n 17.5 Types of Corneal Injuries\n 17.5.1 Chemical Injuries\n 17.5.1.1 Alkali Injury\n 17.5.1.2 Acid Injury\n 17.5.2 Particulate Injury\n 17.5.2.1 Pollution\n 17.5.2.2 Water Pollution\n 17.5.2.3 Non-Infectious Waterborne Infections\n 17.5.2.4 Infectious Waterborne Diseases\n 17.5.2.5 Treatment of Corneal Injury\n 17.6 Retina and Its Diseases\n 17.6.1 Diabetic Macular Edema (DME) and Diabetic Retinopathy (DR)\n 17.6.2 Macular Hole\n 17.6.3 Age-Related Macular Degeneration\n 17.6.4 Retinal Detachment\n 17.6.5 Inherited Retinal Disorders\n 17.6.5.1 Therapies for IRD\n 17.6.5.2 Gene–Environmental Interactions in Inherited Retinal Diseases\n 17.6.6 Glaucoma\n 17.6.6.1 External Therapeutic Drugs That Can Cause Glaucoma\n 17.6.6.2 Treatment for Glaucoma\n 17.7 Environmental Effect on Eye Diseases\n 17.7.1 Air Pollution\n 17.7.2 Light Stress\n 17.7.3 Effect of Smoking/Tobacco Consumption on Ocular Ailments\n 17.8 Microbes and Eye Diseases\n 17.9 Eye Cancers and Environment\n 17.10 Eye Diseases and COVID Infection\n 17.11 Role of Community Screening by Optometrists\n 17.11.1 Community Eye Care\n 17.11.2 Awareness\n 17.12 Role of Community Awareness Programs\n 17.13 The Role of Green Landscapes in Eye Health\n 17.14 Ocular Health and One Health Approach\n References\n Chapter 18 Wastes in One Health – African Perspective\n 18.1 Introduction\n 18.2 Waste Categorization\n 18.3 Plastics\n 18.4 Domestic Garbage\n 18.5 Liquid Waste\n 18.6 Radioactive Waste\n 18.7 Waste Electronic and Electrical Equipment (e-Waste)\n 18.8 Drivers of Wastes Generation in Africa\n 18.9 Poor Handling Practices of Wastes\n 18.10 Knowledge, Attitudes, and Perceptions of Wastes in One Health\n 18.11 Environmental Degradation of Improper Waste Disposal\n 18.12 Impact of Exposure to Waste on Human Health\n 18.13 Contemporary Issues: Waste Management and Antimicrobial Resistance\n 18.14 Waste Management Practices\n 18.15 Actionable Recommendations on Waste in One Health\n References\n Chapter 19 Endocrine Disruptors and Female Reproductive Health: A Problem to Tackle with One Health Perspective\n 19.1 Introduction\n 19.2 Endocrine Disruptors\n 19.3 Human Female Reproductive Tract\n 19.3.1 EDCs and the Ovary\n 19.3.1.1 Bisphenols\n 19.3.1.2 Phthalates\n 19.3.1.3 Polychlorinated Biphenyls (PCB)\n 19.3.1.4 Genistein\n 19.3.2 EDCs and the Endometrium\n 19.3.2.1 Bisphenol A\n 19.3.2.2 Phthalates\n 19.3.2.3 Polychlorinated Biphenyls\n 19.3.2.4 Genistein\n 19.3.3 EDCs and Transgenerational and Multigenerational Effect\n 19.4 Mitigating the Exposure/Impact of EDCs and Future Research Through the “One Health” Approach\n 19.5 Concluding Remarks\n References\n Chapter 20 Emerging and Re-emerging Zoonoses in South Asia: Challenges of One Health\n 20.1 One Health Concept\n 20.2 Zoonoses\n 20.3 Emerging and Re-emerging Zoonoses in South Asia\n 20.3.1 Rabies\n 20.3.2 Leishmaniasis\n 20.3.3 Trypanosomiasis\n 20.3.4 Nipah Virus\n 20.3.5 Coronavirus (SARS, MERS, CoV) Infections\n 20.3.6 Leptospirosis\n 20.3.7 Anthrax\n 20.3.8 Avian Influenza\n 20.3.9 Other Zoonoses\n 20.4 Challenges of Implementing One Health in South Asia\n 20.4.1 Poverty and Overpopulation\n 20.4.2 Identification of Zoonoses in Animals\n 20.4.3 Poor Collaboration Between Different Parties Involved in Zoonosis Control\n 20.4.4 Lack of Awareness\n 20.4.5 Political Instability\n 20.5 Conclusion\n Acknowledgments\n References\n Chapter 21 Impacts of Crop Protection Practices on Human Infectious Diseases: Agroecology as the Preferred Strategy to Integrate Crop Plant Health Within the Extended “One Health” Framework\n 21.1 Introduction\n 21.2 Limits of the Study\n 21.3 A Conceptual Framework to Position Crop Protection Practices\n 21.3.1 Examples of Conventional Crop Protection Practices or Those Aiming at Improving the Efficiency of the Same (=E-Based)\n 21.3.1.1 Synthetic Insecticides\n 21.3.1.2 Synthetic Rodenticides\n 21.3.1.3 Synthetic Herbicides\n 21.3.1.4 Synthetic Bactericides and Fungicides\n 21.3.2 Examples of Substitution (S)-Based Crop Protection Practices\n 21.3.2.1 Crop Plant Resistance\n 21.3.2.2 Trapping, Hunting, and Culling of Vertebrate Pests\n 21.3.2.3 Physical Barriers\n 21.3.2.4 Mineral, Botanical, or Organic Pesticides\n 21.3.2.5 Augmentative Biological Control\n 21.3.2.6 Soil Solarization\n 21.3.3 Examples of Redesign (R)-Based Crop Protection Practices\n 21.3.3.1 Sanitizing Rotations\n 21.3.3.2 Push-Pull\n 21.3.3.3 Crop-Livestock Integration\n 21.3.3.4 Conservation Biological Control with Arthropod Natural Enemies\n 21.3.3.5 Conservation Biological Control with Vertebrate Natural Enemies\n 21.3.3.6 Organic Agriculture\n 21.4 Discussion and Conclusion\n 21.4.1 Irrelevance of Conventional Crop Protection Practices or Those Aiming at Improving the Efficiency of the Same (=“E”-Based)\n 21.4.2 Relevance of Some Substitution (S)-Based and Most Redesign (R)-Based Crop Protection Practices\n 21.4.3 Agroecology as the Preferred Strategy to Integrate Crop Plant Health Within the Extended “One Health” Framework\n References\n Chapter 22 Tackling Antimicrobial Resistance Needs One Health Approach\n 22.1 Antimicrobial Resistance (AMR): A Brief Overview\n 22.2 AMR: Antimicrobials, Their Origin, and Development of Resistance\n 22.3 AMR: Types and Mechanisms\n 22.4 AMR: No Boundaries for Transmission\n 22.5 AMR: Current Status\n 22.5.1 Burden of AMR in Human Health\n 22.5.2 Burden of AMR in Animal Sector\n 22.5.3 AMR in the Environment\n 22.6 AMR: Inter and Intra Transmission Among Humans, Animals, and Environment\n 22.7 One Health Approach for Tackling AMR\n 22.7.1 Action Plan by WHO\n 22.7.2 Tripartite (WHO, FAO, and OIE Working Together)\n 22.8 Constraints in Implementing One Health Approach\n 22.9 Conclusion\n References\n Chapter 23 Eco-epidemiology of Tick-Borne Pathogens: Role of Tick Vectors and Host Animal Community Composition in Their Circulation and Source of Infections\n 23.1 General Features of Tick Biology\n 23.1.1 Ticks as Ectoparasites\n 23.1.2 Tick Life Cycle\n 23.1.3 Tick-Borne Infections (TBIs) and Tick-Borne Pathogens\n 23.2 Ecological Factors Affecting Tick-Borne Agents\n 23.2.1 Reservoirs of TBIs: Domestic and Sylvatic Cycles\n 23.2.2 Biodiversity and the Dilution Effect Model\n 23.3 Ticks and Tick-Transmitted Pathogens in the United States\n 23.3.1 Ticks are the Most Prevalent Sources of Vector-Borne Infections in the United States\n 23.3.2 A New Concern in the Study of Tick-Borne Agents in the United States\n 23.4 Ticks and Tick-Transmitted Pathogens in Sri Lanka\n 23.4.1 Current Knowledge About Ticks and their Hosts in Sri Lanka\n 23.4.2 Tick-Borne Disease Agents and Human Diseases in Sri Lanka\n 23.4.3 Animal Reservoirs of Tick-Borne Disease Agents in Sri Lanka\n 23.4.4 Ecological Considerations Affecting Tick-Borne Disease Agents and Their Transmission in Sri Lanka\n 23.5 The One Health Approach to Understanding Tick-Borne Disease Agents\n 23.6 Conclusions and Future Directions\n Acknowledgments\n References\n Chapter 24 Natural Enemies Against Dengue: Opportunities and Constraints on Biological Control of Dengue Vectors in Sri Lanka\n 24.1 Dengue: The Fastest Spreading Vector-Borne Disease\n 24.2 Management Strategies of Dengue\n 24.3 Biological Control of Dengue\n 24.4 Biological Control of Dengue in Sri Lanka\n 24.4.1 Larvivorous Fish\n 24.4.2 Cyclopoid Copepods\n 24.4.3 Dragonfly Nymphs\n 24.4.4 Bacillus Strains\n 24.5 Carnivorous Mosquito Larvae\n 24.6 Carnivorous Aquatic Plants\n 24.7 Endoparasitic Ciliates with Antagonistic Effect\n 24.8 Ecological Perspective of Biological Control\n 24.9 Opportunities, Constraints, and Way Forward\n Acknowledgments\n References\nSection III Futuristic Approach for One Health\n Chapter 25 Planetary Health: Rethinking Health\n 25.1 Impact of Humans on the Planet\n 25.1.1 Climate Change\n 25.1.2 Ocean Acidification\n 25.1.3 Freshwater\n 25.1.4 Changes in Land Use and Soil Erosion\n 25.1.5 Toxic Chemical Pollution and Exposure\n 25.1.6 Biodiversity Loss\n 25.2 Paradigm Shift: Human to Planetary Health\n 25.3 Approaches to Promote Planetary Health\n 25.3.1 Food\n 25.3.2 Integrated Land Use Planning\n 25.3.3 Female Empowerment\n 25.3.4 Energy\n 25.3.5 Manufacturing of Goods and Services\n 25.3.6 Sustainable and Resilient Cities\n 25.4 Measure Growth, Progress, and Development and Govern Ourselves\n Acknowledgment\n References\n Chapter 26 SARS-CoV-2 and Other Pathogenic Organisms in Food and Water: Health Implications and Environmental Risk\n 26.1 Introduction\n 26.2 SARS-CoV-2 and Other Pathogens in Food and Drinking Water\n 26.3 Food as a Non-Droplet Spreading Route of Pathogen\n 26.4 Water is a Carrier of SARS-CoV-2 With Other Pathogens\n 26.5 Eradication Methods of Pathogen for Safety and Sustainability\n 26.5.1 Chemical Disinfectant\n 26.5.2 Physical Disinfectant\n 26.6 Disadvantage of Chemical Remediation of Foodborne Pathogen\n 26.6.1 Chlorine as Disinfectant to Remove SARS-CoV-2 and its Impact on Ecosystem (Chemical Remediation)\n 26.7 Biological Remediation and its Advantage\n 26.7.1 The Application of Biosurfactant as Antiviral Agent Against COVID-19\n 26.8 Conclusion\n Acknowledgments\n Conflict of Interest\n Funding\n Credit Author Statement\n References\n Chapter 27 Modifying the Anthropocene Equation with One Health Concept\n 27.1 “A” for Anthropocene\n 27.2 The Inseparability of Human, Animal, and Environmental Health; One Health Concept\n 27.3 Trends in Global Environmental Change in Recent Anthropocene\n 27.3.1 Climate Change and Global Warming\n 27.3.2 Biodiversity Loss\n 27.3.3 Altering Biogeochemical Cycles; Nitrogen and Phosphorus Cycles\n 27.3.4 Chemical Pollution\n 27.4 Challenges to One Health in the Recent Anthropocene\n 27.5 From One Health Concept to Practice\n 27.6 Conclusion\n References\n Chapter 28 Bioavailability of Trace Elements in Soils\n 28.1 Introduction\n 28.2 Bioavailability Process in Soil\n 28.3 Factors Affecting Bioavailability Process\n 28.3.1 pH\n 28.3.2 Redox Potential\n 28.3.3 Organic Matter\n 28.3.4 Clay\n 28.3.5 Cation Exchange Capacity\n 28.3.6 Oxides and Hydroxides\n 28.3.7 Inherent Bioavailability Potential of Elements\n 28.4 Soil–Plant Transfer of Trace Elements\n 28.4.1 Assessment of Bioavailability of Trace Metal(loid)s\n 28.4.1.1 Soil Metal Pollution Assessment\n 28.4.1.2 Plant Metal Remediation Assessment\n 28.5 Strategies Used to Control the Bioavailability of TEs\n 28.5.1 Incorporation of Soil Amendments with Soil\n 28.5.1.1 Biochar\n 28.5.1.2 Industrial By-Products\n 28.5.1.3 Natural Minerals\n 28.5.1.4 Metal Oxides\n 28.5.2 Phytomining\n 28.5.3 Phytoremediation\n 28.5.4 Microbial Bioremediation\n 28.5.5 Artificially Established Wetlands\n 28.5.6 Soil Washing\n 28.5.7 Bio-Electrokinetic Remediation\n 28.5.8 Low-Temperature Thermal Desorption\n 28.6 Remarks\n References\n Chapter 29 “Light” as an Environmental Factor for the Well-Being of the “Plant, Animal, and Human Triad”\n 29.1 Introduction\n 29.2 Phototropic Movements in Retina and Visual Function\n 29.3 Phototropism in Plants\n 29.4 Phototropisms and Phototaxis in Animals\n 29.5 Photomorphogenesis\n 29.6 Photosynthesis\n 29.7 Heliotropic Movements in Animals, Humans, and Plants\n 29.8 Heliotropic Movements in Plants – Case Study of Plants Grown at University of Hyderabad\n 29.9 Solar Tracking can be Modeled by Quantum Mechanics\n 29.10 Genetic Basis of Movements\n 29.11 Vision in Animals, Unicellular to Multicellular Organism, and Rhodopsin Cycle\n 29.12 Optogenetics: Photoreceptors, Neural Circuits, and Light-Induced Channels\n 29.13 Metabolites, Circadian Clock, and Sleep Pattern in Humans Under Altered Light Conditions\n 29.14 Light Therapy for Human Diseases\n 29.15 Conclusion and Prospects\n Acknowledgments\n References\nIndex\nEULA




پست ها تصادفی